Bimas HLA Peptide Binding Predictions

Bimas HLA Peptide Binding Predictions predicts and ranks 8-mer, 9-mer, and 10-mer peptides by their dissociation half-time from the MHC class I molecule HLA-A2 using coefficients derived from experimental peptide binding data.

Key Features:

• Predictive Accuracy: Calculates theoretical binding stability by multiplying position- and amino-acid-specific coefficients, reproducing experimental binding stability within a factor of 5.
• Coefficient Table: Uses a table of 180 coefficients (20 amino acids × 9 peptide positions) derived from empirical analysis of 154 peptides to represent position-specific contributions for nonapeptides.
• Independence Assumption: Models each peptide side-chain contribution as independent when estimating overall peptide–HLA-A2 complex stability.
• Ranking Capability: Ranks peptides by predicted dissociation half-time and identifies biologically relevant nonamer peptides among the top 2% of candidates from each source protein.
• Applicability to Candidate Peptides: Predicts binding stability for known self or antigenic nonamers and for all other possible nonamers derivable from their source proteins, and applies to 8-mer, 9-mer, and 10-mer peptides.

Scientific Applications:

• Immunology research: Supports analysis of peptide–MHC interactions for the HLA-A2 allele.
• Vaccine antigen selection: Prioritizes candidate peptides for vaccine development by predicted HLA-A2 binding stability.
• Personalized medicine: Assists individualized immune-response targeting by ranking peptides for HLA-A2 binding.
• Experimental prioritization: Guides selection of peptides for further experimental validation based on predicted stability.

Methodology:

Computes predicted dissociation half-times by multiplying position-specific amino-acid coefficients from a table of 180 coefficients (derived from empirical binding data of 154 peptides for nonapeptides) under the assumption that each side-chain contributes independently to HLA-A2 binding.